Forget SpaceX. These 2 Space Stocks Could Be the Real Winners Of the Coming IPO Frenzy

Rocket Lab reported Q1 revenue of $200.3 million, up 63.5% year over year, with backlog more than doubling to $2.2 billion and 31 new launch contracts signed. AST SpaceMobile posted just $14.7 million in Q1 revenue but has $1.2 billion-plus in contracted commitments, $3.5 billion in cash, and FCC approval for U.S. commercial direct-to-device service. The article argues that SpaceX IPO speculation is boosting sentiment across the public space sector, though both names remain high-risk and richly valued.

Analysis

The SpaceX IPO chatter is functioning less like a single-event catalyst and more like a sector-wide multiple reset. When a category leader is priced at a massive private valuation, public comparables with real contracts but smaller scales tend to get treated as option-like proxies, which is why the move can persist for weeks even if nothing changes operationally. The second-order effect is that capital flows may temporarily favor the most liquid public “picks and shovels” names over later-stage private space assets, especially those tied to launch cadence, ground infrastructure, and government demand.

Rocket Lab looks like the cleaner relative winner in the near term because it offers the market a tangible backlog-to-revenue conversion story, but the valuation now embeds a high probability that Neutron executes on schedule and ramps without major overruns. The risk is that investors are underwriting an eventual launch services monopoly-like moat while ignoring the capital intensity and schedule slip history that usually compresses multiples once the narrative shifts from backlog growth to margin delivery. In other words, the stock is increasingly trading on future credibility, not current earnings power.

AST SpaceMobile is a more asymmetric regulatory-to-commercialization bet: FCC approval reduces the “can they legally do it?” discount, but it does not solve the harder question of how quickly network uptime, handset economics, and carrier partnerships translate into recurring revenue. The blue-sky setup can keep the stock supported for months, but any satellite loss, launch delay, or subscriber adoption miss would hit a name that is still valued as if deployment risk is fading faster than it likely is. The market may also be underestimating competitive pressure from terrestrial carriers and alternative direct-to-device approaches once proof-of-concept turns into a real procurement cycle.

The contrarian view is that the SpaceX IPO could be a local top for enthusiasm rather than a clean boost to all space equities. If the debut is as large and attention-grabbing as rumored, the market may eventually compare every public space name against a much deeper, better-funded benchmark and decide the listed peers deserve lower, not higher, scarcity premiums. That creates a timing mismatch: the trade works best into the IPO window and the first post-listing weeks, but becomes less attractive once the market starts demanding actual unit economics instead of thematic exposure.

Key Decisions for Investors

• Short-dated momentum long ASTS into the SpaceX IPO window; target a 4-8 week trade, but size small because the setup is driven by sentiment more than near-term cash flow. Use a tight stop if launch/approval headlines turn neutral.
• Keep RKLB on a watchlist for a tactical long only on pullbacks, not breakouts; the current setup has already priced in much of the backlog optimism. Prefer call spreads over common to cap downside if Neutron timing slips.
• Pair trade: long ASTS / short a basket of legacy telecom or satellite-adjacent operators if you want regulatory momentum exposure, but hedge aggressively because commercialization risk is still high. Time horizon 3-6 months.
• Avoid chasing the sector post-IPO if SpaceX prices at the top end of the range; that would likely compress rather than expand relative valuations across public names within 1-3 weeks after listing.
• If you want pure event alpha, sell volatility on names with run-up but no fresh catalyst after the IPO date; implieds may stay elevated, but realized moves should fade once the novelty premium is digested.